Business
Sanofi Shares Fall After CEO Change
Sanofi SAN -1.87%decrease; red down pointing triangle shares fell after the drugmaker said Belen Garijo, the chief executive of Germany’s Merck MRK 1.91%increase; green up pointing triangle KGaA, would succeed Paul Hudson as CEO after its board decided not to renew his mandate.
The change at the helm of the French company follows a string of clinical setbacks last year that put its shares under pressure and left investors and analysts wondering whether Sanofi would be able to replace sales from blockbuster Dupixent—an anti-inflammatory drug jointly developed with Regeneron—once the medicine goes off patent.
Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8